Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 5
2007 1
2008 2
2009 2
2010 2
2011 3
2012 3
2013 1
2014 3
2015 4
2016 4
2017 6
2018 9
2019 4
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Dupilumab for the treatment of asthma.
Pelaia C, Vatrella A, Gallelli L, Terracciano R, Navalesi P, Maselli R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Expert Opin Biol Ther. 2017 Dec;17(12):1565-1572. doi: 10.1080/14712598.2017.1387245. Epub 2017 Oct 8. Expert Opin Biol Ther. 2017. PMID: 28990423 Review.
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.
Pelaia C, Calabrese C, Terracciano R, de Blasio F, Vatrella A, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192. Ther Adv Respir Dis. 2018. PMID: 30400762 Free PMC article. Review.
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant.
Pelaia C, Crimi C, Vatrella A, Busceti MT, Gaudio A, Garofalo E, Bruni A, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Pharmacol Res. 2020 May;155:104490. doi: 10.1016/j.phrs.2019.104490. Epub 2019 Nov 1. Pharmacol Res. 2020. PMID: 31682916 Review.
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.
Pelaia C, Busceti MT, Vatrella A, Rago GF, Crimi C, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Pulm Pharmacol Ther. 2019 Oct;58:101830. doi: 10.1016/j.pupt.2019.101830. Epub 2019 Jul 22. Pulm Pharmacol Ther. 2019. PMID: 31344472
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29133975 Free PMC article. Review.
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
Pelaia C, Calabrese C, Vatrella A, Busceti MT, Garofalo E, Lombardo N, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Biomed Res Int. 2018 May 10;2018:4839230. doi: 10.1155/2018/4839230. eCollection 2018. Biomed Res Int. 2018. PMID: 29862274 Free PMC article. Review.
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.
Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: terracciano r. Drug Des Devel Ther. 2018 Mar 21;12:619-628. doi: 10.2147/DDDT.S155307. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29606855 Free PMC article. Review.
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma.
Pelaia G, Vatrella A, Busceti MT, Fabiano F, Terracciano R, Matera MG, Maselli R. Pelaia G, et al. Among authors: terracciano r. Pulm Pharmacol Ther. 2016 Oct;40:15-21. doi: 10.1016/j.pupt.2016.07.001. Epub 2016 Jul 2. Pulm Pharmacol Ther. 2016. PMID: 27381656 Review.
Application of proteomics and peptidomics to COPD.
Pelaia G, Terracciano R, Vatrella A, Gallelli L, Busceti MT, Calabrese C, Stellato C, Savino R, Maselli R. Pelaia G, et al. Among authors: terracciano r. Biomed Res Int. 2014;2014:764581. doi: 10.1155/2014/764581. Epub 2014 May 5. Biomed Res Int. 2014. PMID: 24895607 Free PMC article. Review.
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma.
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Maselli R. Pelaia G, et al. Among authors: terracciano r. Mediators Inflamm. 2015;2015:879783. doi: 10.1155/2015/879783. Epub 2015 Mar 23. Mediators Inflamm. 2015. PMID: 25878402 Free PMC article. Review.
51 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback